Company CVAbout Orchid Pharma Ltd 
Orchid Pharma Ltd
Small Cap
Pharmaceuticals & Drugs
Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries. Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
Company Coordinates
Company Details
Orchid Towers Nungambakkam, 313 Valluvar Kottam High Road Chennai Tamil Nadu : 600034
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 50.72 Cr
Number of Shares
5.07 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Jun-2023
5.07
50.72
9902705
10
Qualified Institutional Placement
15-Sep-2020
4.08
0.41
-88556163
10
Reduction - Court Order
15-Sep-2020
4.08
0.41
-88556163
10
Reduction - Court Order
31-Mar-2020
4.08
40.82
40000072
10
Preferential basis & Amalgamation
30-Mar-2020
8.16
0.82
408164
10
Loan Conversion
27-Jul-2019
4.08
0.41
-88556163
10
Reduction - Court Order
09-Oct-2015
8.9
88.96
3702450
10
Conversion of Debt
09-Oct-2015
8.9
88.96
3702450
10
Conversion of Debt
22-Dec-2014
8.53
85.26
14809801
10
Scheme of Arrangement
22-Dec-2014
8.53
85.26
14809801
10
Scheme of Arrangement
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 15 Schemes (17.46%)
FIIs
Held by 66 FIIs (2.53%)
Promoter with highest holding
Dhanuka Laboratories Limited (69.84%)
Highest Public shareholder
Quant Mutual Fund - Quant Small Cap Fund (6.83%)
Individual Investors Holdings
6.42%
Board of Directors
Management
Designation
Remuneration
Tanu Singla
Independent Director
1.8 lacs
Dharam Vir
Independent Director
1.65 lacs
Mudit Tandon
Independent Director
1.05 lacs
Manoj Goyal
Independent Director
1.9 lacs
Manish Dhanuka
Managing Director
1.18 cr
Mridul Dhanuka
Whole-time Director
1.18 cr
Ram Gopal Agarwal
Chairman (Non-Executive)
25.0 k
Marina Peter
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Cephalosporin API
478.48
73.72%
Non Penicillin Non Cephalosporin FDF
92.09
14.19%
Cephalosporin FDF
60.56
9.33%
Cephalosporin API
Cephalosporin API
Non Penicillin Non Cephalosporin FDF
Non Penicillin Non Cephalosporin FDF
Cephalosporin FDF
Cephalosporin FDF
Stock DNARevenue and Profits:
Net Sales:
217 Cr
(Quarterly Results - Dec 2024)
Net Profit:
21 Cr
Pharmaceuticals & Drugs
INR 3,692 Cr (Small Cap)
32.00
33
0.00%
-0.06
9.72%
2.92
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
